Pharmacokinetic Contributions to Postantibiotic Effects
- 1 November 1994
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 27 (5) , 377-392
- https://doi.org/10.2165/00003088-199427050-00005
Abstract
The postantibiotic effect (PAE) refers to a period of time after complete removal of an antimicrobial during which there is no growth of the target organism. The PAE appears to be a feature of most antimicrobial agents and has been documented with a variety of common bacterial pathogens. Various factors influence the presence or duration of the PAE including the type of organism, type of antimicrobial, concentration of antimicrobial, duration of antimicrobial exposure, antimicrobial combinations, and inoculum and medium used. β-Lactams demonstrate a PAE against Gram-positive cocci, but produce only a short PAE with Gram-negative bacilli. Antimicrobial agents that inhibit RNA or protein synthesis have a PAE against Gram-positive cocci and Gram-negative bacilli. In vivo studies of aminoglycosides suggest that area under the plasma concentration-time curve is the pharmacokinetic parameter that best correlates with clinical efficacy. This is thought to be due to the concentration-dependent killing and PAE possessed by these antimicrobials. Animal and human studies have reported that once-daily administration of aminoglycoside is as effective as, or more effective than, and possibly less toxic than traditional multiple daily administration.Keywords
This publication has 96 references indexed in Scilit:
- The postantibiotic suppressive effect of l-ofloxacin, an optically active isomer of ofloxacinDiagnostic Microbiology and Infectious Disease, 1992
- Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal modelsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin inKlebsiella pneumoniae pneumonia and septicemia in leukopenic ratsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinoloneDiagnostic Microbiology and Infectious Disease, 1989
- Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal modelEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Postantibiotic and bactericidal effect of imipenem againstPseudomonas aeruginosaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Kinetics of antimicrobial activityThe Journal of Pediatrics, 1986
- Comparative Trial of Single‐Dose Versus Twice‐Daily Sisomicin in Bacteriuric PatientsThe Journal of Clinical Pharmacology, 1977
- Isoniazid uptake and growth inhibition of mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposuresTubercle, 1969